Aethlon Medical Inc. (AEMD)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

0.34

-4.90%

After-hours Dec 13, 2024, 06:33 PM EST

Company Description

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States.

The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes.

Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer.

The company was founded in 1999 and is based in San Diego, California.

Aethlon Medical Inc.

Country	United States
IPO Date	Mar 4, 1999
Industry	Medical - Devices
Sector	Healthcare
Employees	14
CEO	James B. Frakes M.B.A.

Contact Details

Address: 11555 Sorrento Valley Road San Diego, California United States
Website	https://www.aethlonmedical.com

Stock Details

Ticker Symbol	AEMD
Exchange	NASDAQ
Fiscal Year	April - March
Reporting Currency	USD
CIK Code	0000882291
CUSIP Number	00808Y307
ISIN Number	US00808Y4061
Employer ID	13-3632859
SIC Code	3841

Key Executives

Name	Position
James B. Frakes M.B.A.	Chief Executive Officer, Chief Financial Officer, Secretary & Director
Guy F. Cipriani BS (Eng.), MBA	Senior Vice President & Chief Operating Officer
Dr. Steven P. LaRosa M.D.	Chief Medical Officer

Latest SEC Filings

Date	Type	Title
Nov 15, 2024	S-8	Filing
Nov 13, 2024	10-Q	Quarterly Report
Nov 13, 2024	8-K	Current Report
Nov 12, 2024	8-K	Current Report
Oct 03, 2024	8-K	Current Report
Oct 02, 2024	8-K	Current Report
Oct 01, 2024	4	Filing
Oct 01, 2024	4	Filing
Oct 01, 2024	4	Filing
Sep 19, 2024	8-K	Current Report

View All SEC Filings